Microneedle Array Patch Pierces Bacterial Biofilms
By HospiMedica International staff writers Posted on 12 Oct 2021 |
Image: Flexible microneedles effectively eradicate biofilm infections (Photo courtesy of Vincent Walter/ Purdue University)
A flexible polymer composite microneedle array bypasses biofilm in chronic wounds to deliver both oxygen and bactericidal agents simultaneously.
The polymeric microneedles, developed at Purdue University (Lafayette, IN, USA) and Virginia Polytechnic Institute and State University (Virginia Tech; Blacksburg, USA), are manufactured by ultraviolet (UV) polymerization of flexible polyethylene terephthalate, which conformably attaches to the human body. Containing calcium peroxide and polyvinylpyrrolidone, the microneedle array can effectively elevate oxygen levels from 8 to 12 ppm, as well as provide strong bactericidal effects on both liquid and biofilm bacteria cultures, commonly found in dermal wounds.
Results from an ex-vivo assay study on a porcine wound model showed successful insertion of the biodegradable microneedles into the tissue, while also providing effective bactericidal properties against both Gram-positive and Gram-negative microbes within the complex tissue matrix. The microneedles also demonstrated high levels of cytocompatibility, with less than 10% of apoptosis throughout six days of continuous exposure to human dermal fibroblast cells. The study was published on July 19, 2021, in ACS Applied Bio Materials.
“Bacteria biofilm acts as a shield, hindering antibiotics from reaching infected cells and tissues. The traditional method to bypass biofilm is for physicians to peel it off, which is painful to patients and doesn't discriminate unhealthy tissue from healthy tissue,” said senior author Rahim Rahimi, PhD, of the Purdue School of Materials Engineering. “A flexible microneedle array can provide a better approach for increasing the effectiveness of topical tissue oxygenation as well as the treatment of infected wounds with intrinsically antibiotic resistant biofilms.”
Chronic non-healing wounds, such as diabetic foot ulcer (DFU), are colonized by bacteria that often develop into biofilms that act as a physicochemical barrier to therapeutics and tissue oxygenation, leading to chronic inflammation and tissue hypoxia. Although wound debridement and vigorous mechanical abrasion techniques are often used by clinicians to manage and remove biofilms from wound surfaces, such methods are highly nonselective and painful.
Related Links:
Purdue University
Virginia Polytechnic Institute and State University
The polymeric microneedles, developed at Purdue University (Lafayette, IN, USA) and Virginia Polytechnic Institute and State University (Virginia Tech; Blacksburg, USA), are manufactured by ultraviolet (UV) polymerization of flexible polyethylene terephthalate, which conformably attaches to the human body. Containing calcium peroxide and polyvinylpyrrolidone, the microneedle array can effectively elevate oxygen levels from 8 to 12 ppm, as well as provide strong bactericidal effects on both liquid and biofilm bacteria cultures, commonly found in dermal wounds.
Results from an ex-vivo assay study on a porcine wound model showed successful insertion of the biodegradable microneedles into the tissue, while also providing effective bactericidal properties against both Gram-positive and Gram-negative microbes within the complex tissue matrix. The microneedles also demonstrated high levels of cytocompatibility, with less than 10% of apoptosis throughout six days of continuous exposure to human dermal fibroblast cells. The study was published on July 19, 2021, in ACS Applied Bio Materials.
“Bacteria biofilm acts as a shield, hindering antibiotics from reaching infected cells and tissues. The traditional method to bypass biofilm is for physicians to peel it off, which is painful to patients and doesn't discriminate unhealthy tissue from healthy tissue,” said senior author Rahim Rahimi, PhD, of the Purdue School of Materials Engineering. “A flexible microneedle array can provide a better approach for increasing the effectiveness of topical tissue oxygenation as well as the treatment of infected wounds with intrinsically antibiotic resistant biofilms.”
Chronic non-healing wounds, such as diabetic foot ulcer (DFU), are colonized by bacteria that often develop into biofilms that act as a physicochemical barrier to therapeutics and tissue oxygenation, leading to chronic inflammation and tissue hypoxia. Although wound debridement and vigorous mechanical abrasion techniques are often used by clinicians to manage and remove biofilms from wound surfaces, such methods are highly nonselective and painful.
Related Links:
Purdue University
Virginia Polytechnic Institute and State University
Latest Critical Care News
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure
- Plasma Irradiation Promotes Faster Bone Healing
- New Device Treats Acute Kidney Injury from Sepsis
- Study Confirms Safety of DCB-Only Strategy for Treating De Novo Left Main Coronary Artery Disease
- Revascularization Improves Quality of Life for Patients with Chronic Limb Threatening Ischemia
- AI-Driven Prediction Models Accurately Predict Critical Care Patient Deterioration
- Preventive PCI for High-Risk Coronary Plaques Reduces Cardiac Events
- AI Diagnostic Tool Guides Rapid Diagnosis and Prediction of Sepsis
- World's First AI-Powered Sepsis Alert System Detects Sepsis in One Minute
- Smartphone Magnetometer Uses Magnetized Hydrogel to Measure Biomarkers for Disease Diagnosis
- New Technology to Revolutionize Valvular Heart Disease Care